Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
clinical trials
3
×
life sciences
national blog main
national top stories
3
×
texas blog main
3
×
texas top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
al guillem
arena pharmaceuticals
astrazeneca
baran d. sumer
biomarker
blaze bioscience
blueprint medicines
blz-100
cancer prevention and research institute of texas
cardiovascular disease
What
medicine
3
×
cancer
drug
fda
agent
approved
better
dallas
deeper
developing
dna
eisai
fingerprint
flags
funding
genetic
going
help
higher
imaging
incidence
lorcaserin
loss
maker
market
marketing
matter
million
nd
new
oks
oncon
onconano
patients
post
pulls
raised
raises
remove
risks
Language
unset
Current search:
xconomy.com
×
medicine
×
" texas blog main "
×
" national top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million